
Markets with Madison: Analysts eyeing Fisher & Paykel hit, upside for aged care
FPH is extraordinarily overvalued, Forsyth Barr says.
FPH is extraordinarily overvalued, Forsyth Barr says.
Restrictions part of US effort to impede Beijing’s ambitions while ensuring stable supply.
Flu season and China Covid outbreak boosts demand.
An energetic Fisher and Paykel Healthcare led the way.
"We need more space": Mega-development will roll out over decades.
F&P Healthcare sees earnings returning to pre-Covid levels in the first half to September.
Fisher & Paykel Healthcare's net profit dropped by 28 per cent to more normal levels.
The healthcare manufacturer withholds guidance for current year.
F&P Healthcare is expected to report a sharp fall in annual net profit on Wednesday.
The best of business in New Zealand set to be honoured in the annual Top 200 awards.
Fisher & Paykel Healthcare has released its first half result.
Market's attention will be on what lies ahead as more countries come to grips with Covid.
F&P Healthcare's turnover edged lower in the first four months of its financial year.
For the second day running, the New Zealand sharemarket was driven down by F&P Healthcare.
Mid-year results in the Herald Brokers Picks game don't all reflect the NZX-50 returns.
The respiratory products maker recorded a record profit of more than $500m.
F&P Healthcare and Ryman have been standouts among Australasian healthcare companies.
Loving family photo shared online weeks before killings.
Brokers select their top five companies for 2021 in our annual stock picking game.
Fisher & Paykel Healthcare reaps rewards.
F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.
Vaccine is no silver bullet but at least brings the horizons of this crisis into focus.
Trade thinned out before the long Labour Day weekend.
Could F&P Healthcare's earnings upgrade be too conservative?
F&P Healthcare said Covid-19 demand would drive earnings sharply higher in 2021.
The re-emergency of Covid-19 has cast more doubt on NZ corporate earnings.
Kiwi dollar steady but shares take a hit.
Innovative company has looked after the health of its customers -- and its investors.